Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

globenewswire.com - Nxera Pharma - Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter 2026
Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter 2026
GlobeNewswire

Tokyo, Japan and Cambridge, UK, 7 August 2026 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the second quarter ended 30…

forbes.com - Harini Gopalakrishnan - ​Pharma's AI Inflection Point: Five Lessons For CAIOs
​Pharma's AI Inflection Point: Five Lessons For CAIOs
Forbes

Harini Gopalakrishnan, Founder of theHaze.ai & Industry GTM, Vespa,ai. AI companies are entering the life science services fray. Anthropic's recent launch of Claude Science is a good example of that shift, positioning an AI company not only as a…

globenewswire.com - Zealand Pharma - Zealand Pharma conference call on August 13 at 2pm CEST (8am ET) to present second quarter 2026 financial results
Zealand Pharma conference call on August 13 at 2pm CEST (8am ET) to present second quarter 2026 financial results
GlobeNewswire

Press Release – No. 14 / 2026 Zealand Pharma conference call on August 13 at 2pm CEST (8am ET) to present second quarter 2026 financial results Copenhagen, Denmark, August 6, 2026 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no.

smh.com.au - Elias Visontay - 'Talk to your doctor': Pharma giants' weight loss ads skirt Australian law
'Talk to your doctor': Pharma giants' weight loss ads skirt Australian law
The Sydney Morning Herald

Health experts have hit out at the emergence of US-inspired ads spruiking prescription medicines, as pharma giants behind blockbuster weight loss drugs skirt local laws banning promotions of their products by encouraging Australians to proactively…

marketbeat.com - Ascendis Pharma A/S (NASDAQ:ASND) Receives Average Recommendation of 'Buy' from Analysts
Ascendis Pharma A/S (NASDAQ:ASND) Receives Average Recommendation of 'Buy' from Analysts
MarketBeat

Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) has been given an average rating of 'Buy' by the nineteen analysts that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold rating, sixteen…

seekingalpha.com - Jonathan Weber - Novo Nordisk: The Market Has Lost Its Mind, Too Cheap To Ignore (NYSE:NVO)
Novo Nordisk: The Market Has Lost Its Mind, Too Cheap To Ignore (NYSE:NVO)
Seeking Alpha

Novo Nordisk A/S delivered a strong Q2, beating revenue by 10% and EPS by over 20%, yet shares dipped post-earnings. NVO's adjusted revenues rose 7% year-over-year, driven by international and obesity care growth, despite US pricing headwinds and…

cnbc.com - Jim Cramer - Jim Cramer's top 10 things to watch in the stock market Thursday
Jim Cramer's top 10 things to watch in the stock market Thursday
CNBC

My top 10 things to watch Thursday, Aug. 6 1. Mixed bag for futures this morning. S & P and Dow are modestly green. The Nasdaq is lower, weighed down by the post-earnings slides in data-storage makers Sandisk and Western Digital. WTI crude is up…

newswire.ca - Vimy Pharma - Harmony Acquisitions Announces Proposed Qualifying Transaction with Vimy Pharmaceuticals
Harmony Acquisitions Announces Proposed Qualifying Transaction with Vimy Pharmaceuticals
CNW

VANCOUVER, BC, Aug. 6, 2026 /CNW/ -- Harmony Acquisitions Corp. (TSXV: MONY.P) ('Harmony' or the 'Company') and Vimy Pharmaceuticals Inc. ('Vimy Pharma') are pleased to announce that they have entered into a non-binding letter of intent dated…

thehindu.com - V. Swathi - Musi Riverfront Development Project gets Environmental Clearance
Musi Riverfront Development Project gets Environmental Clearance
The Hindu

The Musi Riverfront Development, the flagship project of the Telangana government portrayed as a paradigm changer in terms of city's development, gained a major step forward by way of Environmental Clearance. Phase-1 of the project has been granted…

cnbc.com - Liz Napolitano - This drug researcher just reported earnings and could keep rallying on biotech bounceback, JPMorgan says
This drug researcher just reported earnings and could keep rallying on biotech bounceback, JPMorgan says
CNBC

Charles River Laboratories is likely to keep rallying as it shows signs of leveraging a comeback in biotechnology investments to strengthen its core contract research organization business, according to JPMorgan. The investment bank upgraded the…

cnbc.com - Reuters - U.S. FDA approves first mRNA flu shot from Moderna
U.S. FDA approves first mRNA flu shot from Moderna
CNBC

Adam Glanzman | Bloomberg | Getty Images The U.S. Food and Drug Administration has approved Moderna's flu vaccine for people aged 50 and older, the company said on Wednesday, marking the first approval of a messenger ⁠RNA-based vaccine for…

dynamitenews.com - Sreeja Chowdhury - Stock Market Update: Sensex, Nifty Close In Green; RBI Decision, Falling Crude Oil Prices Lift Dalal Street | Dynamite News
Stock Market Update: Sensex, Nifty Close In Green; RBI Decision, Falling Crude Oil Prices Lift Dalal Street | Dynamite News
News: Today's News Headlines & Daily Updates from Sports, Movies, Politics, Business | Dynamite News

Post Published By: Sreeja Chowdhury Updated: 6 August 2026, 3:56 PM IST Mumbai: The Indian stock market concluded its trading session on an upbeat note after the Reserve Bank of India left interest rates unchanged and benchmark indices moved up on…

afaqs.com - afaqs! news bureau - WPP reports 2.9% decline in India business in H1
WPP reports 2.9% decline in India business in H1
afaqs!

WPP reported a 2.9% decline in its India business during the first half of 2026, attributing the slowdown to the timing of sporting events. India contributed to a 3.8% decline in the group's Asia Pacific (APAC) business, alongside a 4.7% fall in…

seekingalpha.com - Albert Anthony - MetLife's Q2 Earnings Beat Reaffirms The Buy Case As Organic Growth Stands Out (NYSE:MET)
MetLife's Q2 Earnings Beat Reaffirms The Buy Case As Organic Growth Stands Out (NYSE:MET)
Seeking Alpha

Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…

semafor.com - Shelly Banjo - Novo Nordisk faces a rough patch
Novo Nordisk faces a rough patch
Semafor

Novo Nordisk's CFO has spent the last few days on the phone trying to reassure investors that the GLP-leader hasn't lost a step. The market isn't buying it. Novo's shares have fallen 15% this year, tumbling further this week after guidance missed…

Receive a Daily briefing on Pharma Industry News

Get Started